BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7779593)

  • 1. Lung cancer.
    Hansen HH; Rørth M
    Cancer Chemother Biol Response Modif; 1994; 15():484-500. PubMed ID: 7779593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer.
    Hansen HH; Rørth M
    Cancer Chemother Biol Response Modif; 1992; 13():455-70. PubMed ID: 1327045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer.
    Hansen HH; Rørth M
    Cancer Chemother Biol Response Modif; 1997; 17():444-63. PubMed ID: 9551225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer.
    Hansen HH; Rørth M
    Cancer Chemother Biol Response Modif; 1993; 14():442-61. PubMed ID: 8312112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer.
    Hansen HH; Rørth M
    Cancer Chemother Biol Response Modif; 1996; 16():474-86. PubMed ID: 8639395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer.
    Hansen HH; Rørth M
    Cancer Chemother Biol Response Modif; 1999; 18():336-56. PubMed ID: 10800491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of lung cancer--state of the art in 2000].
    Nakanishi Y; Inoue K; Hara N
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1247-52. PubMed ID: 10945023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
    Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
    Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.
    Sandler AB
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):38-41. PubMed ID: 9535210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
    Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
    J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
    Hainsworth JD; Stroup SL; Greco FA
    Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer.
    Ettinger DS
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):148-50. PubMed ID: 10210554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer.
    Brugger W; Fetscher S; Hasse J; Frommhold H; Pressler K; Mertelsmann R; Engelhardt R; Kanz L
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):42-8. PubMed ID: 9535211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of small cell lung cancer.
    Sandler AB
    Semin Oncol; 1997 Aug; 24(4):463-76. PubMed ID: 9280226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-hour paclitaxel in the treatment of non-small cell lung cancer.
    Hainsworth JD; Greco FA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):98-101. PubMed ID: 9007133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.